Atlas Trials

Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI

Clinical trial NCT00587275 · TERMINATED

Trial details

NCT number
NCT00587275
Sponsor
Ocera Therapeutics
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease (GERD)
Start date
2007-10-01
Primary completion
2008-06-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.